title: Disulfiram for the treatment of cocaine dependence.
abstract: BACKGROUND
  Cocaine dependence is a disorder for which no pharmacological treatment of proven efficacy exists, advances in the neurobiology could guide future medication development.
  
  
  OBJECTIVE
  To evaluate the efficacy and the acceptability of disulfiram for cocaine dependence.
  
  
  METHODS
  We searched: PubMed, EMBASE, CINAHL (up to January 2008), the Cochrane Central Register of Controlled Trials (CENTRAL-The Cochrane Library, 1, 2009), reference lists of trials, main electronic sources of ongoing trials, conference proceedings.
  
  
  METHODS
  Randomised and controlled clinical trials comparing disulfiram alone or associated with psychosocial intervention with no intervention, placebo, or other pharmacological intervention for the treatment of cocaine dependence.
  
  
  METHODS
  Three reviewers independently assessed trial quality and extracted data.
  
  
  RESULTS
  Seven studies, 492 participants, met the inclusion criteriaDisulfiram versus placebo: no statistically significant results for dropouts but a trend favouring disulfiram, two studies, 87 participants, RR 0.82 (95% CI 0.66 to 1.03). One more study, 107 participants, favouring disulfiram, was excluded from meta-analysis due high heterogeneity, RR 0.34 (95% CI 0.20 to 0.58). For cocaine use, it was not possible to pool together primary studies, results from single studies showed that, one, out of four comparisons, was in favour of disulfiram (number of weeks abstinence, 20 participants, WMD 4.50 (95% CI 2.93 to 6.07).Disulfiram versus naltrexone: no statistically significant results for dropouts but a trend favouring disulfiram, three studies, 131 participants, RR 0.67 (95% CI 0.45 to 1.01). No significant difference for cocaine use was seen in the only study that considered this outcome.Disulfiram versus no pharmacological treatment: for cocaine use: a statistically significant difference in favour of disulfiram, one study, two comparisons, 90 participants: maximum weeks of consecutive abstinence, WMD 2.10 (95% CI 0.69 to 3.51); number of subjects achieving 3 or more weeks of consecutive abstinence, RR 1.88 (95% CI 1.09 to 3.23).
  
  
  CONCLUSIONS
  There is low evidence, at the present, supporting the clinical use of disulfiram for the treatment of cocaine dependence. Larger randomised investigations are needed investigating relevant outcomes and reporting data to allow comparisons of results between studies. Results from ongoing studies will be added as soon as their results will be available.
authors.affiliation: Social-Health Division, Health District 8 (ASL 8) Cagliari, Cittadella della Salute, padiglione C, via Romagna 16, Cagliari, Sardinia, Italy, 09127.
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Pani
authors.forename: Emanuela
authors.initials: E
authors.lastname: Trogu
authors.forename: Rosangela
authors.initials: R
authors.lastname: Vacca
authors.forename: Laura
authors.initials: L
authors.lastname: Amato
authors.forename: Simona
authors.initials: S
authors.lastname: Vecchi
authors.forename: Marina
authors.initials: M
authors.lastname: Davoli
mesh_terms: D019970:Cocaine-Related Disorders / Q000188:drug therapy*; D004221:Disulfiram / Q000627:therapeutic use*; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D009292:Narcotic Antagonists; D009271:Naltrexone; D004221:Disulfiram